Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44176,1801,1.20 [1.12-1.29],6.97551770965876e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43452,434,1.63 [1.41-1.88],4.1087463756770094e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,48290,333,1.36 [1.15-1.60],0.000266211214668
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33390,1573,1.47 [1.36-1.60],1.88398743698245e-21
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48182,225,1.45 [1.19-1.77],0.0002601507926703
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45044,171,1.47 [1.17-1.85],0.0008465925089729
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50656,223,1.45 [1.19-1.77],0.0002826237718122
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50664,153,1.14 [0.89-1.45],0.2943868409517007
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44001,116,1.88 [1.43-2.47],7.031868432879827e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48994,236,1.36 [1.12-1.65],0.0016522638639994
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48911,153,1.55 [1.22-1.97],0.000303452090963
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50823,132,0.97 [0.75-1.26],0.8119470958535022
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50812,165,1.28 [1.02-1.62],0.0333688693270446
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50799,152,1.34 [1.05-1.70],0.0173882094879318
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,50124,103,1.22 [0.91-1.64],0.1770522951430301
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",48387,827,1.15 [1.04-1.28],0.0081128423030372
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47842,282,1.42 [1.19-1.69],0.0001179614573541
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48130,570,1.07 [0.95-1.22],0.2687427121895325
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40746,128,1.09 [0.84-1.42],0.5240970946004869
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40726,108,0.95 [0.71-1.26],0.7236272496398419
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41144,526,1.02 [0.89-1.16],0.8176945841188794
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41161,543,1.03 [0.91-1.18],0.6067662797592632
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23068,663,1.11 [0.99-1.25],0.0742923953061333
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18447,234,0.87 [0.71-1.07],0.185172605389828
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40725,107,1.22 [0.91-1.62],0.1873213418373506
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,45383,1563,1.36 [1.26-1.47],2.6872089882384128e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",48274,662,0.98 [0.87-1.10],0.674466671279558
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49908,234,0.99 [0.81-1.21],0.925580175155223
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50978,218,1.04 [0.85-1.28],0.6753140770348504
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,50429,135,0.73 [0.57-0.94],0.014262579819181
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50997,132,1.02 [0.78-1.32],0.8965223065659055
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Stomach,51089,101,0.93 [0.69-1.25],0.6328621810102009
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,50548,586,0.98 [0.87-1.11],0.797551945424661
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51002,214,1.09 [0.89-1.33],0.4285670263936815
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51011,180,1.18 [0.95-1.47],0.1400807661833646
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50888,103,0.93 [0.70-1.25],0.6281327449385857
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",50893,102,0.92 [0.69-1.23],0.5791306020431068
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,50729,389,0.81 [0.70-0.94],0.0062027214957742
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51030,170,0.83 [0.66-1.03],0.0935985799729702
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,50815,363,0.92 [0.79-1.08],0.3188130037259855
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of breast,27517,138,1.02 [0.79-1.31],0.8983990973272701
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,27013,992,1.02 [0.93-1.12],0.7287782383607553
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,48502,392,1.27 [1.09-1.47],0.0019491843512641
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47848,688,1.36 [1.21-1.52],1.563551098803373e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47848,688,1.36 [1.21-1.52],1.563551098803373e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44088,909,1.42 [1.28-1.57],1.4789753723246084e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50000,136,1.34 [1.04-1.74],0.0232419607828361
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50483,168,1.02 [0.81-1.29],0.843870332020902
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41274,2332,1.23 [1.15-1.32],7.172929648363053e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48044,1072,1.08 [0.98-1.18],0.121438632678104
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,46476,263,2.51 [2.09-3.01],8.660838255190747e-23
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48736,218,1.51 [1.23-1.85],8.570432509006493e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46452,239,2.39 [1.97-2.89],7.894796865787971e-19
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,47309,1096,1.71 [1.55-1.88],2.3965530362054717e-28
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,47274,1061,1.70 [1.54-1.87],6.25617322640056e-27
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,47276,364,1.13 [0.95-1.34],0.1669558816853953
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",47279,360,1.13 [0.96-1.35],0.1462321135826081
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40930,1988,1.18 [1.10-1.27],6.321288618257834e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39199,257,1.47 [1.22-1.78],6.678701043773867e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40780,1838,1.17 [1.08-1.26],4.563189951348642e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39042,100,1.42 [1.05-1.91],0.0212390185164329
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39110,168,2.02 [1.60-2.54],2.018320428087593e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,43214,1300,1.22 [1.12-1.33],4.017271620320983e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",42367,453,1.18 [1.02-1.37],0.0257064820180324
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50287,339,1.10 [0.93-1.30],0.2740003489463768
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50417,246,1.09 [0.89-1.32],0.4096480788460431
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,47565,116,1.29 [0.98-1.71],0.073484843771404
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50896,116,1.29 [0.97-1.70],0.0769626827475822
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42030,116,1.30 [0.98-1.73],0.0665818639566168
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Alcohol dependence,47590,141,1.16 [0.90-1.51],0.251441336899601
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,47477,115,1.46 [1.10-1.93],0.0088152864322159
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42022,108,1.28 [0.96-1.71],0.0967985330244112
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",42562,648,1.26 [1.12-1.42],0.0001325849617841
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression,47915,569,1.25 [1.11-1.42],0.000392446806409
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,42058,496,1.21 [1.06-1.39],0.0052468461921947
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42168,254,1.13 [0.93-1.36],0.2135112308257061
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Other anxiety disorders,48185,131,0.98 [0.76-1.27],0.8814016597458932
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,43656,2918,1.15 [1.09-1.22],1.2189610633773369e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39649,260,0.95 [0.79-1.15],0.599429048534661
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50793,207,0.91 [0.74-1.11],0.3538533833322306
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,48408,948,1.24 [1.12-1.37],1.620271791083751e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,47758,298,1.59 [1.34-1.88],1.370843155631018e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,47618,158,1.13 [0.89-1.43],0.3173937138627078
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50486,143,1.09 [0.85-1.39],0.497885012370897
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49424,158,1.06 [0.83-1.35],0.6482215778525623
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,47784,324,1.05 [0.89-1.25],0.5434997968940367
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,49943,247,1.10 [0.91-1.34],0.3200986253550353
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48752,1321,1.04 [0.96-1.13],0.3136970299955413
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47668,237,0.89 [0.74-1.08],0.2426736921938156
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48196,765,1.06 [0.95-1.18],0.2841834042719086
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50481,164,1.65 [1.31-2.08],1.953551693427566e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,50432,115,1.90 [1.45-2.49],3.891198515770689e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,50102,243,1.22 [1.01-1.48],0.0411037323655062
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49760,726,1.09 [0.97-1.22],0.1339431414440585
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49454,420,1.06 [0.92-1.23],0.4285638439083111
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49183,149,0.99 [0.77-1.26],0.9172886735344647
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49271,237,0.90 [0.74-1.09],0.2977873608041264
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49187,153,1.22 [0.96-1.55],0.0993056816571022
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43973,320,1.36 [1.15-1.60],0.0003721851560092
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,44445,792,1.12 [1.01-1.25],0.0363383819229018
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49068,427,1.43 [1.23-1.65],1.7252214072454336e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50413,103,2.47 [1.84-3.31],1.3553451096636283e-09
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4347,103,2.25 [1.68-3.01],5.00370722352903e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",46169,103,2.55 [1.90-3.43],4.720298655537101e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,49741,183,1.06 [0.85-1.32],0.632600129702831
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49659,101,1.01 [0.75-1.37],0.9329263873925544
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",49708,175,0.95 [0.76-1.19],0.6672461360946809
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49989,194,1.11 [0.90-1.38],0.3213898364386597
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50869,266,1.05 [0.87-1.26],0.6202351442718419
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,49344,201,1.11 [0.90-1.38],0.3132775582254418
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36177,6503,1.21 [1.16-1.27],6.082669896710319e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49821,137,1.24 [0.96-1.60],0.0989417962699744
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38070,4478,1.18 [1.12-1.24],4.801478740520984e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,38134,4542,1.19 [1.13-1.26],3.074063617908001e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33744,152,2.45 [1.91-3.13],9.272929865229249e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",46720,2384,1.29 [1.21-1.38],6.026348730975479e-14
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,45763,1427,1.25 [1.15-1.36],1.1939583207288077e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48987,487,1.26 [1.10-1.45],0.0008469216791548
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49465,965,1.35 [1.22-1.49],3.469155356240741e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50816,191,1.31 [1.05-1.63],0.0162712964200166
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44932,596,1.53 [1.35-1.74],3.9071431319515675e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,46191,1891,1.32 [1.23-1.42],1.7687612936252645e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49435,219,1.04 [0.85-1.28],0.6868698966717515
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49643,457,1.11 [0.97-1.28],0.1297679220330867
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49396,180,1.45 [1.16-1.81],0.0010519335030599
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49398,182,1.41 [1.13-1.76],0.0021763379752867
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33765,173,1.48 [1.18-1.87],0.0007832142618149
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42348,116,1.36 [1.03-1.79],0.0323696535797561
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,42473,241,1.31 [1.07-1.59],0.007474725017698
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28200,234,1.35 [1.11-1.65],0.0032831924772125
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28841,875,1.44 [1.29-1.61],6.883760971862674e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,42365,133,1.31 [1.01-1.70],0.0447481785693778
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,42416,184,1.41 [1.12-1.76],0.002864242152819
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48955,412,1.47 [1.27-1.71],5.09161196877433e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49273,309,1.72 [1.45-2.03],4.2577765619642256e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49340,260,1.76 [1.47-2.12],1.7706137455861015e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49496,230,1.74 [1.43-2.12],2.9300931643640633e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48734,155,1.32 [1.04-1.68],0.023487219753589
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48832,253,1.52 [1.26-1.83],1.2569350993699675e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48147,280,1.21 [1.01-1.45],0.0377649990012015
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48104,237,1.14 [0.94-1.39],0.1861126784682367
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50647,228,1.11 [0.91-1.35],0.3141006614320329
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,48807,940,1.04 [0.94-1.15],0.4326632425446619
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,48665,173,1.38 [1.09-1.73],0.00629076690894
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40704,4085,1.17 [1.11-1.23],7.547407790694993e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50702,211,0.97 [0.80-1.19],0.7941594288356323
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,47329,452,1.44 [1.25-1.66],4.500279460870045e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",47272,395,1.41 [1.21-1.64],9.204057499833908e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49211,499,1.33 [1.16-1.52],2.8902457640490155e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49200,488,1.35 [1.18-1.55],1.221229799348726e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49476,1213,0.97 [0.89-1.06],0.4927560900108499
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,48454,191,0.92 [0.74-1.14],0.4524847140523758
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,48509,246,0.97 [0.80-1.17],0.7233777932661175
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49037,774,0.96 [0.86-1.07],0.432014310670257
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,48628,365,0.92 [0.79-1.07],0.2780713936065564
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23490,124,1.19 [0.91-1.56],0.2100065225362092
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,45612,2005,1.18 [1.10-1.26],2.626235892573908e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,48717,349,1.27 [1.08-1.49],0.0043629194454871
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",48770,402,1.23 [1.06-1.44],0.0070177426282404
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",48770,402,1.23 [1.06-1.44],0.0070177426282404
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",47624,1653,1.13 [1.05-1.22],0.0009649557661
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,36444,1653,1.17 [1.09-1.26],4.089327429485877e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35907,1653,1.18 [1.09-1.27],2.4030822271239984e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36418,1627,1.17 [1.08-1.26],6.041732665376832e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50335,178,1.84 [1.48-2.30],6.264510263582997e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,48141,137,2.11 [1.64-2.71],5.071214888934256e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",50493,137,2.10 [1.63-2.69],7.248050218430728e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48128,124,2.07 [1.59-2.70],5.796637098916065e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,46933,220,1.42 [1.16-1.74],0.0006928978242505
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,47184,471,1.40 [1.21-1.60],2.704238571518015e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,48548,215,1.44 [1.18-1.77],0.0004304090264865
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34712,11527,1.05 [1.02-1.09],0.0049316649012274
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50030,832,1.05 [0.94-1.16],0.3796225843211404
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51013,180,1.01 [0.81-1.26],0.9128391492437608
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,51021,166,1.00 [0.79-1.25],0.972269569734059
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,49411,213,1.03 [0.85-1.27],0.7397558142992418
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49396,198,0.93 [0.75-1.15],0.5184397867128452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50996,200,1.10 [0.89-1.36],0.3764608180082136
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49393,195,1.13 [0.91-1.39],0.2767435202345396
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48864,154,0.92 [0.72-1.17],0.4840295655095586
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50857,103,0.76 [0.57-1.01],0.0556979496202727
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38848,542,1.24 [1.09-1.42],0.001019791864408
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",42596,4290,1.05 [1.00-1.10],0.0523949238711017
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,38979,673,0.91 [0.81-1.02],0.1009647512774946
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39688,1382,1.00 [0.92-1.09],0.9488922574028889
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38457,151,1.29 [1.01-1.65],0.0419347559517042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38715,409,1.15 [0.99-1.34],0.0740199655140824
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38417,111,0.75 [0.56-0.99],0.0458299592713084
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,38609,303,1.24 [1.04-1.47],0.0168773648923656
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38553,247,1.29 [1.06-1.56],0.0102844639710943
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50807,170,1.39 [1.11-1.75],0.0048015314935025
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,38556,250,1.25 [1.03-1.51],0.023159222335659
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39913,1607,1.06 [0.98-1.14],0.156728622383433
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,50772,250,0.84 [0.70-1.01],0.0676380112965476
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39168,862,0.98 [0.89-1.09],0.7325198699898587
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38643,337,1.15 [0.97-1.35],0.0990769486521343
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50757,310,0.96 [0.81-1.13],0.6067526508942505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,50725,203,0.77 [0.63-0.94],0.010378376115073
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,44710,3216,1.01 [0.96-1.07],0.6942381783113042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,42672,1178,1.06 [0.97-1.16],0.218329309405992
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,41750,256,0.92 [0.76-1.11],0.3721658624101921
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,41691,197,1.15 [0.93-1.42],0.2062046715887981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,43206,1712,0.99 [0.92-1.07],0.7901557689516657
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49132,1509,1.13 [1.05-1.23],0.0015086682122592
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,39942,3973,1.09 [1.04-1.15],0.0008455156812841
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50401,117,1.26 [0.96-1.67],0.0988188646482616
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50941,161,1.29 [1.02-1.64],0.0342618105081917
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,47784,161,1.30 [1.03-1.65],0.0293476870452281
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47745,122,1.38 [1.05-1.81],0.0195964401853409
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50809,273,1.23 [1.02-1.47],0.0269411939566271
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,47896,273,1.24 [1.03-1.48],0.0230365377590314
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47869,246,1.21 [0.99-1.46],0.0562844821515182
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48849,1226,1.12 [1.02-1.22],0.0128074971039694
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48835,1212,1.12 [1.02-1.22],0.0132247405050385
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36170,201,1.12 [0.91-1.39],0.2900980132458214
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal stricture,50156,201,1.12 [0.90-1.38],0.3095684461863754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36101,132,1.10 [0.84-1.43],0.4922829350307185
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37166,1197,1.06 [0.97-1.16],0.1890138597096141
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36293,324,1.00 [0.85-1.18],0.9814917607251834
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36541,572,1.28 [1.13-1.46],9.749209636124037e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,47810,513,1.28 [1.12-1.46],0.0002731027063751
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50177,178,1.23 [0.98-1.54],0.068241570435286
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36253,284,0.92 [0.77-1.10],0.3789267373309539
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36111,142,0.90 [0.70-1.16],0.4269525960099166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37714,1745,1.09 [1.01-1.17],0.0223773763008111
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,36510,541,1.12 [0.98-1.28],0.0893707373780773
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50148,149,1.27 [1.00-1.62],0.0507993303794337
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,49460,249,1.27 [1.05-1.53],0.0136937783224417
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,49348,137,1.19 [0.92-1.54],0.1845290774106329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",48350,1243,1.13 [1.04-1.23],0.0056438146872567
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,48101,994,1.07 [0.97-1.18],0.1610714054843067
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,47305,198,1.03 [0.83-1.27],0.7869200618640757
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47211,104,1.40 [1.04-1.87],0.0243250610025337
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,47242,135,1.33 [1.03-1.72],0.0282703358413701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),50727,135,1.32 [1.03-1.71],0.0316301084915902
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,48306,624,1.35 [1.19-1.52],1.3368522358743154e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47823,141,1.72 [1.33-2.21],2.7773137700660743e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,47798,116,1.84 [1.39-2.43],1.720543914124798e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47782,100,1.31 [0.97-1.78],0.0776662207114106
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48076,394,1.21 [1.04-1.41],0.0130136147098627
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,48062,380,1.21 [1.04-1.42],0.0143925686104555
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44791,3086,1.06 [1.01-1.13],0.0281528832592477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50169,208,1.01 [0.82-1.24],0.8989368523664873
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50236,897,0.95 [0.86-1.04],0.2695129635269979
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47901,1148,1.12 [1.02-1.22],0.0148746079452728
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49264,785,1.21 [1.08-1.35],0.0005755441392736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48655,176,0.95 [0.76-1.19],0.6718151803766463
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48984,505,1.31 [1.15-1.50],8.083612595552284e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50521,183,1.06 [0.85-1.32],0.6250704706188501
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50482,144,0.97 [0.76-1.25],0.8280950302565869
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50448,110,0.87 [0.66-1.16],0.3485022729147524
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50483,112,1.01 [0.76-1.34],0.9582473988456898
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50478,107,1.02 [0.76-1.37],0.8854345324098828
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49450,111,1.24 [0.93-1.64],0.1360587467768448
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50060,721,0.93 [0.83-1.03],0.1747969287356631
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46939,186,1.04 [0.83-1.30],0.738873604341665
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46954,201,1.05 [0.85-1.30],0.6222770965803524
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46906,153,0.99 [0.78-1.26],0.9161826955776672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47186,433,1.03 [0.90-1.19],0.6452599996049092
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47141,388,1.02 [0.88-1.19],0.7564719152290457
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36772,7909,1.08 [1.04-1.13],6.40304441213035e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39984,4598,1.06 [1.01-1.11],0.0271911699405783
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46038,2399,1.03 [0.97-1.10],0.3205236473257691
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35688,302,1.37 [1.16-1.63],0.0003154851767284
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36313,927,1.18 [1.07-1.30],0.0013514368157416
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50239,290,1.35 [1.13-1.61],0.0007399789245142
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50261,262,1.43 [1.19-1.71],0.000146358158527
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37660,2274,1.00 [0.94-1.07],0.931363009480268
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42764,2274,1.01 [0.94-1.07],0.8783288298107741
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35519,133,0.86 [0.66-1.13],0.280955400974853
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49933,130,0.87 [0.67-1.14],0.314746763150748
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35834,448,1.12 [0.97-1.29],0.1266805473224262
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35527,141,1.00 [0.78-1.29],0.991210308949414
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35944,558,1.03 [0.91-1.18],0.6180919583084248
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50752,277,0.98 [0.81-1.17],0.7870897912346784
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36429,1043,0.99 [0.90-1.09],0.879337860230363
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36173,787,1.07 [0.96-1.19],0.235426402359517
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37948,2562,1.03 [0.97-1.10],0.3321265981458168
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35516,130,1.30 [1.00-1.69],0.0522791046204185
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35855,469,0.97 [0.85-1.12],0.7115395320056299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35499,113,0.85 [0.64-1.12],0.2457015632046809
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35505,119,0.97 [0.74-1.27],0.8122938406033857
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36346,960,0.98 [0.89-1.08],0.6951004052186034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36214,828,1.02 [0.91-1.13],0.7746476507854361
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39542,555,1.15 [1.01-1.30],0.0316733779044624
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49971,255,1.72 [1.44-2.07],4.104407413443292e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49825,109,1.55 [1.17-2.06],0.002120557623387
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44152,123,1.15 [0.88-1.50],0.3174440008482451
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,44612,583,1.16 [1.02-1.31],0.0231803405722729
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45864,1835,1.08 [1.01-1.16],0.030548496181254
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,44404,375,1.13 [0.96-1.31],0.1314816854055083
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44198,169,1.29 [1.02-1.62],0.0319960137374191
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",45472,1443,1.06 [0.98-1.15],0.1407038761767237
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44129,100,1.06 [0.79-1.43],0.6978075771312
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44490,461,1.00 [0.87-1.15],0.9831267244179972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44227,198,1.02 [0.83-1.27],0.828430378703342
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44183,154,0.92 [0.73-1.17],0.4979727419846667
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44307,278,1.07 [0.89-1.27],0.4859106476290791
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44153,124,0.97 [0.75-1.27],0.8457520462073039
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44631,602,1.08 [0.95-1.22],0.2232607101260842
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44258,619,1.00 [0.88-1.12],0.960839069741922
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43776,137,1.07 [0.83-1.38],0.6099744742409277
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43814,175,1.35 [1.08-1.69],0.0088574446840604
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43839,200,0.77 [0.63-0.94],0.0110964639798091
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43738,99,0.85 [0.63-1.15],0.2915280410236736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43867,228,0.86 [0.70-1.05],0.1483029010978482
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43841,202,0.79 [0.64-0.98],0.035220212868818
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44163,524,1.02 [0.89-1.16],0.7875342822524428
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43748,109,1.12 [0.84-1.49],0.4407430877425545
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43793,154,0.97 [0.76-1.24],0.8197846067392457
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43892,253,0.93 [0.77-1.12],0.4506729544507171
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43758,119,1.19 [0.91-1.56],0.2130691831367588
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",44520,881,1.18 [1.07-1.31],0.0014382575825847
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43968,329,1.10 [0.93-1.29],0.2699482128057883
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44115,476,1.18 [1.03-1.36],0.015306574781168
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,47308,340,1.26 [1.07-1.48],0.005105596453914
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,47743,775,1.18 [1.06-1.32],0.0026177248945074
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47065,97,1.28 [0.94-1.74],0.1131927339637378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47084,116,1.04 [0.79-1.37],0.8040211194068448
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47170,202,1.01 [0.82-1.25],0.8937946026349498
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40495,8449,1.06 [1.02-1.10],0.003765732851315
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20234,1262,1.14 [1.04-1.24],0.0047135584644791
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45835,500,1.60 [1.40-1.83],8.142919369255184e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45470,135,1.19 [0.92-1.55],0.1902413408146746
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46045,108,2.18 [1.64-2.91],8.650820914894415e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46073,136,2.49 [1.93-3.21],2.2531683788140588e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46067,130,2.04 [1.57-2.65],1.1205496564497253e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50339,488,1.05 [0.92-1.21],0.4563183006167114
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50182,137,1.96 [1.52-2.52],1.8297689950749877e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50203,352,0.97 [0.83-1.14],0.7349961849952643
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50021,170,1.11 [0.89-1.40],0.3538286843822652
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,46640,2088,1.05 [0.98-1.13],0.1348976937772422
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,44746,194,1.10 [0.89-1.36],0.3868488988882633
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44714,162,1.13 [0.90-1.43],0.2981517544258715
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45102,550,1.15 [1.01-1.31],0.0393126646310047
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44779,227,1.15 [0.95-1.41],0.1595502735139607
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45909,1357,1.02 [0.94-1.11],0.6524989590589347
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19530,558,1.15 [1.00-1.31],0.0459712232961562
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19077,105,1.18 [0.87-1.59],0.2862166250497018
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19073,101,1.22 [0.90-1.65],0.1898913806512343
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19129,157,1.07 [0.84-1.37],0.5616104524041907
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19132,160,1.16 [0.91-1.48],0.2200917299240473
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19187,215,1.20 [0.97-1.48],0.0854033508884738
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27254,470,0.99 [0.87-1.14],0.925599894141764
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26929,145,1.13 [0.88-1.45],0.3265805755598135
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26950,166,1.08 [0.85-1.35],0.5366563323741329
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26894,110,0.86 [0.65-1.14],0.3019388516702925
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27194,555,0.87 [0.77-0.99],0.0329697284020267
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26772,133,0.82 [0.64-1.05],0.1212635466499753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26886,247,0.86 [0.72-1.04],0.1173653805193295
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25130,4572,0.96 [0.92-1.01],0.1046360591375376
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20919,361,0.86 [0.74-1.01],0.0649320953249934
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20654,96,1.10 [0.82-1.49],0.5230835196054976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20725,167,0.75 [0.60-0.94],0.0115449795914852
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21353,795,0.87 [0.78-0.97],0.010154904778295
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20963,405,0.87 [0.75-1.01],0.0625819036308371
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21514,956,1.02 [0.93-1.13],0.6498633077852491
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20874,316,1.06 [0.90-1.26],0.46888154269354
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20996,438,0.99 [0.86-1.15],0.9379642937435644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20656,98,1.05 [0.78-1.42],0.752414130464592
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20745,187,0.87 [0.70-1.08],0.1990821785031706
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27532,264,0.87 [0.73-1.04],0.1181337506200256
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27544,251,0.85 [0.71-1.02],0.0761027925894971
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27570,140,0.83 [0.65-1.06],0.1361121396980571
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27559,153,0.87 [0.69-1.10],0.2343100319211315
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20704,146,0.88 [0.69-1.13],0.3202796017532269
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20674,116,0.94 [0.72-1.24],0.6660957482022334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20701,143,1.03 [0.81-1.32],0.7865174051039026
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27463,466,0.92 [0.80-1.05],0.2094848279974693
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21890,1332,0.96 [0.89-1.05],0.3757480757349509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21424,866,0.97 [0.88-1.08],0.5912667178513343
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27549,196,0.94 [0.76-1.16],0.5549013712243218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21023,465,0.95 [0.83-1.09],0.4892150375860604
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20881,323,1.04 [0.88-1.22],0.6660195546976126
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21444,886,1.03 [0.93-1.14],0.528332995335637
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female infertility,20674,116,0.94 [0.71-1.24],0.6469169115690263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20667,109,0.93 [0.70-1.24],0.6327420989883142
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27565,878,0.96 [0.86-1.07],0.4568573769888577
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27571,1197,0.97 [0.88-1.07],0.592841999013404
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27567,476,0.88 [0.77-1.01],0.0666590803743162
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27228,137,0.87 [0.67-1.12],0.2681767823127947
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27281,190,0.73 [0.60-0.90],0.0033760516359999
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27253,162,1.07 [0.85-1.35],0.5642337698776358
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27585,163,1.09 [0.87-1.38],0.4558644137339196
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27587,160,1.09 [0.86-1.38],0.474829034855351
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27583,421,1.01 [0.87-1.17],0.8813025995733175
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27290,128,1.08 [0.83-1.40],0.5682171981099209
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27393,231,0.99 [0.82-1.21],0.9590265847834724
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26834,147,1.07 [0.83-1.37],0.6172238322711427
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26889,202,0.91 [0.74-1.12],0.3757719803896716
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26939,252,1.06 [0.88-1.28],0.5386605422205066
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26834,147,0.85 [0.66-1.09],0.1942543071093041
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26825,138,0.92 [0.72-1.19],0.5386753637216531
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26836,149,0.92 [0.72-1.17],0.4849563662479097
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26604,230,0.93 [0.76-1.14],0.501962446141992
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26811,437,1.03 [0.89-1.20],0.6633880701088999
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27043,669,1.00 [0.88-1.13],0.938503550835156
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27588,169,0.93 [0.74-1.18],0.5612901167087614
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26129,128,0.95 [0.73-1.23],0.7048256402228399
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26477,103,1.13 [0.84-1.52],0.4304206865841825
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27596,340,0.89 [0.76-1.05],0.1756538174405054
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27516,260,0.82 [0.68-0.99],0.0383647864195543
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27583,253,1.02 [0.85-1.24],0.8115975586525648
PLA2G10,Group 10 secretory phospholipase A2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27573,243,1.04 [0.86-1.26],0.6837414688164664
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50292,121,1.47 [1.12-1.93],0.0056988027240976
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46013,1186,1.08 [0.99-1.18],0.0868694000116128
